References
- Papatsonis DN, Van Geijn HP, Ader HJ, et al. Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol 1997;90:230–4
- Roos C, Spaanderman ME, Schuit E, et al. Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial. JAMA 2013;309:41–7
- Lockwood CJ, Senyei AE, Dische MR, et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991;325:669–74
- van Baaren GJ, Vis JY, Wilms FF, et al. Predictive value of cervical length measurement and fibronectin testing in threatened preterm labor. Obstet Gynecol 2014;123:1185–92
- Roos C, Scheepers LH, Bloemenkamp KW, et al. Assessment of perinatal outcome after sustained tocolysis in early labour (APOSTEL-II trial). BMC Pregnancy Childb 2009;9:42--6
- Boots AB, Sanchez-Ramos L, Bowers DM, et al. The short-term prediction of preterm birth: a systematic review and diagnostic metaanalysis. Am J Obstet Gynecol 2014;210:54 e1–10
- DeFranco EA, Lewis DF, Odibo AO. Improving the screening accuracy for preterm labor: is the combination of fetal fibronectin and cervical length in symptomatic patients a useful predictor of preterm birth? A systematic review. Am J Obstet Gynecol 2013;208:233 e1–6
- Sananes N, Langer B, Gaudineau A, et al. Prediction of spontaneous preterm delivery in singleton pregnancies: where are we and where are we going? A review of literature. J Obstet Gynaecol 2014;34:457--61
- Parry E, Roos C, Stone P, et al. The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour. Aust NZ J Obstet Gynaecol 2014;54:231–6
- Rothwell PM. Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet 2005;365:176–86